医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

NEOFECT USA to Benefit from Korean IPO Debut

2018年11月29日 AM12:32
このエントリーをはてなブックマークに追加


 

SAN FRANCISCO

Korean-American med-tech company NEOFECT today officially began trading on the KOSDAQ, securing more than $17 million in funding. The company, which makes gamified rehabilitation solutions to help stroke survivors and individuals with spinal cord injuries, musculoskeletal disorders, or neurological conditions, had been valued at more than $114 million. As of market close in Korea, shares were being traded at $6.83.

The Korean IPO will propel NEOFECT’s U.S. operations, enabling the company to further expand its footprint in the U.S. and help more people with neurological and musculoskeletal injuries recover and improve their quality of life.

“The IPO will escalate manufacturing activities and expedite our software development roadmap, including our proprietary AI-based algorithms, so we can better meet the demands of an aging population increasingly at risk for stroke and dementia,” says Scott Kim, co-founder and CEO of NEOFECT USA. “At the same time, it will enable us to ramp up our marketing efforts in the United States, which is the biggest market for our business.”

Over the past 18 months, NEOFECT expanded its direct-to-consumer market and has supported more than 700 consumers using its at-home solutions.

NEOFECT’s line of artificial intelligence and VR-like rehabilitation solutions, including its flagship product, the RAPAEL Smart Glove for Home, is used worldwide by individual patients and clinical partners, like the U.S. Department of Veterans Affairs, NewYork-Presbyterian, the Rehabilitation Institute of Chicago, and Barrow Neurological Institute. The company recently branched out from rehabilitation solutions with the development of the NeoMano, a robotic glove that helps people with hand paralysis operate more independently.

Published studies in the Journal of Physical Therapy Science and the Journal of NeuroEngineering and Rehabilitation, research conducted by Stanford and presented at the American Academy of Neurology’s annual event, and studies conducted by the National Rehabilitation Center in Korea demonstrate the efficacy of NEOFECT’s award-winning solutions.

About NEOFECT

Med-tech startup NEOFECT helps stroke survivors and people with spinal cord injuries, musculoskeletal disorders, or neurological conditions regain independence and live fuller, more active lives. Its game-based rehabilitation solutions deliver more engaging, quantifiable therapy to improve cognitive, hand, and upper arm function, while its robotic orthosis creates an artificial grip to increase hand mobility. https://home.neofect.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20181128005511/en/

CONTACT

Gregory FCA for NEOFECT
Katie Johnston, 610-228-2248
katiej@gregoryfca.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • AMRA、身体組成の非侵襲的測定を実現する磁気共鳴診断ソフトウエアアプリケーションのAMRA® Profilerで米国FDAの承認を取得
  • AMRA用于机体成分无创评估的磁共振诊断软件AMRA® Profiler获得美国FDA核准
  • Haidian District People’s Court in Beijing Issues Injunction Order Restraining Aihua Pan from Using Business License and Corporate Seal of Sinovac Beijing
  • CDISC and Cohen Veterans Bioscience Announce Release of First Data Standard to Improve Research for Post Traumatic Stress Disorder
  • 武田薬品とニューヨーク科学アカデミーによる”2019 Innovators in Science Award”の受賞者発表について